According to a recently published report by Roots Analysis, the rising demand for biologics and ongoing advancements are driving the filtration market growth
The global filtration market is anticipated to grow at a CAGR of 9% from 2023-2035, reaching USD 15 billion by 2035.
Filtration is the process of separating solid particulate matter from liquid or gaseous state of matter by using a porous filter medium. With the ability to remove / separate microscopic contaminants, pathogens and other particulate matter from fluids, filtration processes have profound implications in the pharmaceutical and associated industries. Biomanufacturing is one such industry where filtration forms an integral part of the process; it is used for purification and sterilization of biologics and other ancillary materials required for manufacturing of biologics. Further, the extraction of biomolecules from culture media and the downstream separation procedures (such as protein purification, viral clearance, API filtration) also relies on filtration technologies. Filtration system is an essential component of the biopharmaceutical manufacturing process, which is designed to purify biological products, such as vaccines, therapeutic proteins and monoclonal antibodies by removing unwanted particles, such as colloidal materials and microorganisms from cells, proteins, small molecules and nucleic acids, and obtain contaminant free products. Some of the commonly used biopharmaceutical filtration techniques include (in alphabetical order) microfiltration, nanofiltration and ultrafiltration.
To order this 160+ page report, which features 100+ figures and 130+ tables, please visit https://www.rootsanalysis.com/reports/global-filtration-market.html
Various factors contribute to the market growth associated with the filtration systems. These factors include high throughput of equipment, lesser associated cost, improved product quality, better shelf life and increase safety. The afore-mentioned benefits associated with the biopharmaceutical filtration systems are anticipated to contribute to the market growth of these systems. In fact, owing to the various advantages of filtration systems, several stakeholders have emerged in this domain to offer novel filtration systems.
One of the primary restraints associated with the market growth of this industry is loss of products. The filtration process can result in the loss of some of the product, particularly when using smaller pore-sized filters. This may result into the increase in production cost. Further, filters can become clogged over time, reducing their efficiency and requiring replacement. This can add to the cost of production and increase downtime, thereby restricting the adoption of these filters and limiting the growth of filtration market.
Despite the challenges associated with this market, several innovators are developing filtration technologies to automate processes that have the ability to provide both separation and purification, with an aim to enhance efficiency. However, stakeholders involved in the manufacturing of filtration systems face various challenges due to the high cell densities and initiatives of biopharmaceutical manufacturers to employ single-use technologies and sensor incorporated filtration systems at an increasingly larger scale. To mitigate the existing concerns, players are expanding their capacity, employing high-performance filters. Moreover, big players in the pharmaceutical industry are moving away from immobile and rigid systems, with bulky stainless-steel vessels and fixed attachments, towards more flexible, automated, robust and scalable disposable systems. Owing to this, in the coming years, the biopharmaceutical filtration market is expected to continue to grow.
The filtration market report also includes detailed profiles of key players (listed below) that offer filtration products:
You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/global-filtration-market/request-sample.html
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner
SUBSCRIBE TO INDUSTRY UPDATES